1 |
Pilat U, Dechat T, Bertrand AT et al (2013) The muscle dystrophy-causing lamin A/C mutant does not impair the functions of the nucleoplasmic lamin complex in mice. J Cell Sci 126, 1753-1762
DOI
|
2 |
Odgren PR, Pratt CH, Mackay CA et al (2010) Disheveled hair and ear (Dhe), a spontaneous mouse Lmna mutation modeling human laminopathies. PLoS One 5, e9959
DOI
|
3 |
Heng MY, Lin ST, Verret L et al (2013) Lamin B1 mediates cell-autonomous neuropathology in a leukodystrophy mouse model. J Clin Invest 123, 2719-2729
DOI
|
4 |
Mounkes LC, Kozlov SV, Rottman JN and Stewart CL (2005) Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum Mol Genet 14, 2167-2180
DOI
|
5 |
Arimura T, Helbling-Leclerc A, Massart C et al (2005) Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum Mol Genet 14, 155-169
DOI
|
6 |
Dechat T, Shimi T, Adam SA et al (2007) Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging. Proc Natl Acad Sci U S A 104, 4955-4960
DOI
|
7 |
Lee SJ, Jung YS, Yoon MH et al (2016) Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype. J Clin Invest 126, 3879-3893
DOI
|
8 |
Smigiel R, Jakubial A, Esteves-Vieira V et al (2010) Novel frameshifting mutations of the ZMPSTE24 gene in two siblings affected with restrictive dermopathy and review of the mutations described in the literature. Am J Med Genet 152A, 447-452
DOI
|
9 |
Yu CE, Oshima J, Fu YH et al (1996) Positional cloning of the Werner’s syndrome gene. Science 272, 258-262
DOI
|
10 |
Mok Q, Curley R, Tolmie J and Marsden R (1990) Restrictive dermopathy: a report of three cases. J Met Genet 27, 315-319
DOI
|
11 |
Hisama FM, Lessel D, Leistritz D et al (2011) Coronary artery disease in a Werner syndrome-like form of progeria characterized by low levels of progerin, a splice variant of lamin A. Am J Med Genet 155A, 3002-3006
|
12 |
Hisama FM, Kubisch C, Martin GM and Oshima J (2012) Clinical utility gene card for: Werner syndrome. Eur J Hum Genet 20, 1-3
|
13 |
Goto M, Horiuchi Y, Tanimoto K, Ishii T and Nakashima H (1978) Werner’s syndrome: analysis of 15 cases with a review of the Japanese literature. J Am Geriatr Soc 26, 341-347
DOI
|
14 |
Padiath QS, Saigoh K, Schiffmann R et al (2006) Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat Genet 38, 1114-1123
DOI
|
15 |
Sullivan T, Escalante-Alcalde D, Bhatt H et al (1999) Loss of A-type lamin expression compromise nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 147, 913-920
DOI
|
16 |
Garg A, Subramanyam L, Agarwal AK et al (2009) Atypical progeroid syndrome due to heterozygous missense LMNA mutations. J Clin Endocrinol Metab 94, 4971-1983
DOI
|
17 |
Shackleton S, Lloyd DJ, Jackson SN et al (2000) LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 24, 153-156
DOI
|
18 |
Schuster J, Sundblom J, Thuresson AC et al (2011) Genomic duplications mediate overexpression of lamin B1 in adult-onset autosomal dominant leukodystrophy with autonomic symptoms. Neurogenetics 12, 65-72
DOI
|
19 |
Eriksson M, Brown WT, Gordon LB et al (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423, 293-298
DOI
|
20 |
Capell B, Erdos M, Medigan J and Fiordalisi J (2005) Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Pro Natl Acad Sci U S A 102, 12879-12884
DOI
|
21 |
Rodriguez JI, Perez-Alonso P, Funes R and Perez-Rodriguez J (1999) Lethal neonatal Hutchinson-Gilford progeria syndrome. Am J Med Genet 82, 242-248
DOI
|
22 |
Gillar PJ, Kaye CI and McCourt JW (1991) Progressive early dermatologic changes in Hutchinson-Gilford progeria syndrome. Pediatr Dermatol 8, 199-206
DOI
|
23 |
Chen L, Lee L, Kudlow BA et al (2003) LMNA mutations in atypical Werner’s syndrome. Lancet 362, 440-445
DOI
|
24 |
Merideth MA, Gordon LB, Clauss S et al (2008) Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 358, 592-604
DOI
|
25 |
Salamat M, Dhar PK, Neagu DL and Lyon JB (2010) Aortic calcification in a patient with Hutchinson-Gilford progeria syndrome. Pediatr Cardiol 31, 925-926
DOI
|
26 |
Scaffidi P (2006) Lamin A-dependent nuclear defects in human aging. Science 312, 1059-1063
DOI
|
27 |
Fong L, Frost D, Meta M, Qiao X and Yang S (2006) A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. Science 311, 1621-1623
DOI
|
28 |
Gordon LB, Kleinman ME, Miller DT et al (2012) Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 109, 16666-16671
DOI
|
29 |
Verstraeten VL, Peckham LA, Olive M et al (2011) Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defect. Proc Natl Acad Sci U S A 108, 4997-5002
DOI
|
30 |
Osorio FG, Navarro CL, Cadinanos J et al (2011) Splicing-directed therapy in a new mouse model of human accelerated aging. Sci Transl Med 3, 106ra107
|
31 |
McKenna T, Baek JH and Eriksson M (2013) Laminopathies. Genetic Disorders chapter 2, 28-64
|
32 |
Cronshaw JM, Kruchinsky AN, Zhang W, Chait BT and Matunis MJ (2002) Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 158, 915-927
DOI
|
33 |
Bonne G, Mercuri E, Muchir A et al (2000) Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 48, 170-180
DOI
|
34 |
Gordon LB, Kleinman ME, Massaro J et al (2016) Clinical trial of the protein farnesylation inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in children with Hutchinson-Gilford progeria syndrome. Circulation 134, 114-125
DOI
|
35 |
Aebi U, Cohn J, Buhle L and Gerace L (1986) The nuclear lamina is a meshwork of intermediate-type filaments. Nature 323, 560-564
DOI
|
36 |
Choi JC, Muchir A, Wu W and Iwata S (2012) Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C mutation. Sci Transl Med 4, 144ra102
DOI
|
37 |
Kieran MW, Gordon L and Kleinman M (2007) New approaches to progeria. Pediatrics 120, 834-841
DOI
|
38 |
Ramos FJ, Chen SC, Garelick MG et al (2012) Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescue cardiac and skeletal muscle function, and extends survival. Sci Transl Med 4, 144ra103
DOI
|
39 |
Emery AE and Dreifuss FE (1966) Unusual type of benign x-linked muscular dystrophy. J Neurol Neurosurg Psychiatry 29, 338-342
DOI
|
40 |
Muchir A and Worman HJ (2007) Emery-Dreifuss muscular dystrophy. Curr Neurol Neurosci Rep 7, 78-83
DOI
|
41 |
Helbling-Leclerc A, Bonne G and Schwartz K (2002) Emery-Dreifuss muscular dystrophy. Eur J Hum Genet 10, 157-161
DOI
|
42 |
Stewart CL, Kozlov S, Fong LG and Young SG (2007) Mouse models of the laminopathies. Exp Cell Res 313, 2144-2156
DOI
|
43 |
Canki-Klain N, Recan D, Milicic D et al (2000) Clinical variability and molecular diagnosis in a four-generation family with X-linked Emery-Dreifuss muscular dystrophy. Croat Med J 41, 389-395
|
44 |
Fatkin D, MacRae C, Sasaki T et al (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341, 1715-1724
DOI
|
45 |
Fisher D, Chaudhary N (1986) cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc Ntl Acad Sci U S A 83, 6450-6454
DOI
|
46 |
Muchir A, Bonne G, van der Kooi AJ et al (2000) Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances. Hum Mol Genet 9, 1453-1459
DOI
|
47 |
Yuan WL, Huang CY, Wang JF et al (2009) R25G mutation in exon 1 of LMNA gene is associated with dilated cardiomyopathy and limb-girdle muscular dystrophy 1B. Chin Med J 122, 2840-2845
|
48 |
McPherson E, Turner L, Zador I, Reynolds K, Macgregor D and Giampietro PF (2009) Ovarian failure and dilated cardiomyopathy due to a novel lamin mutation. Am J Med Genet 149A, 567-572
DOI
|
49 |
Lin F, Worman HJ (1993) Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 268, 16321-16326
|
50 |
Barrowman J, Hamblet C, Geoge CM and Michaelis S (2008) Analysis of prelamin A biogenesis reveals the nucleus to be a CaaX processing compartment. Mol Biol Cell 19, 5398-5408
DOI
|
51 |
Barrowman J, Hamblet C, Kane MS and Michaelis S (2012) Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24. PLoS One 7, e32120
DOI
|
52 |
Landires I, Pascale JM and Motta J (2007) The position of the mutation within the LMNA gene determines the type and extent of tissue involvement in laminopathies. Clin Genet 71, 592-593
DOI
|
53 |
Broers JLV, Ramaekers FCS, Bonne G, Yaou RB and Hutchison CJ (2006) Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 86, 967-1008
DOI
|
54 |
Kitten GT and Nigg EA (1991) The CaaX motif is required for isoprenylation, carboxyl methylation, and nuclear membrane association of lamin B2. J Cell Biol 113, 13-23
DOI
|
55 |
Coffinier C, Jung HJ, Li Z et al (2010) Direct synthesis of lamin A, bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no detectable pathology in mice. J Biol Chem 285, 20818-20826
DOI
|
56 |
Ben Yaou R, Muchir A, Arimura T et al (2005) Genetics of laminopathies. Novartis Found Symp 264, 81-90
|
57 |
Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) p53 mutations in human cancers. Science 253, 49-53
DOI
|
58 |
Zastrow MS, Vlcek S and Wilson KL (2004) Proteins that bind A-type lamins: integrating isolated clues. J Cell Sci 117, 979-987
DOI
|
59 |
Salpingidou G, Smertenko A, Hausmanowa-Petrucewicz I, Hussey PJ and Hutchison CJ (2007) A novel role for the nuclear membrane protein emerin in association of the centrosome to the outer nuclear membrane. J Cell Biol 178, 897-904
DOI
|
60 |
Chang W, Folker ES, Worman HJ and Gundersen GG (2013) Emerin organizes actin flow for nuclear movement and centrosome orientation in migrating fibroblasts. Mol Biol Cell 24, 3869-3880
DOI
|
61 |
Constantinescu D, Gray HL, Sammak PJ, Schatten GP and Csoka AB (2006) Lamin A/C expression is a marker of mouse and human embryonic stem cell differentiation. Stem Cells 24, 177-185
DOI
|
62 |
Rober RA, Weber K and Osborn M (1989) Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development 105, 365-378
|
63 |
Wang Y, Herron AJ and Worman HJ (2006) Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy. Hum Mol Genet 15, 2479-2489
DOI
|
64 |
Briand N and Collas P (2018) Laminopathy-causing lamin A mutations reconfigure lamina-associated domains and local spatial chromatin conformation. Nucleus 9, 216-226
DOI
|
65 |
Chojnowski A, Ong PF and Dreesen O (2015) Nuclear lamina remodeling and its implications for human disease. Cell Tissue Res 360, 621-631
DOI
|
66 |
Gruenbaum Y and Foisner R (2015) Lamins: Nuclear intermediate filament proteins with fundamental functions in nuclear mechanics and genome regulation. Annu Rev Biochem 84, 131-164
DOI
|
67 |
Clements L, Manilal S, Love DR and Morris GE (2000) Direct interaction between emerin and lamin A. Biochem Biophys Res Commun 267, 709-714
DOI
|
68 |
Worman HJ (2012) Nuclear lamins and laminopathies. J Pathol 226, 316-325
DOI
|
69 |
Wojtanik KM, Edgemon K, Viswanadha S et al (2009) The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation. J Lipid Res 50, 1068-1079
DOI
|
70 |
Mounkes LC, Kozlov S, Hernandez L, Sullivan T and Stewart CL (2003) A progeroid syndrome in mice is caused by defects in A-type lamins. Nature 423, 298-301
DOI
|
71 |
Varga R, Eriksson M, Erdos MR et al (2006) Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 103, 3250-3255
DOI
|
72 |
Kubben N, Voncken JW, Konings G et al (2011) Post-natal myogenic and adipogenic developmental: defects and metabolic impairment upon loss of A-type lamins. Nucleus 2, 195-207
DOI
|
73 |
Osorio FG, Navarro CL, Cadinanos J et al (2011) Splicing-directed therapy in a new mouse model of human accelerated aging. Sci Transl Med 3, 106ra107
|
74 |
Vergnes L, Peterfy M, Bergo MO, Young SG and Reue K (2004) Lamin B1 is required for mouse development and nuclear integrity. Proc Natl Acad Sci U S A 101, 10428-10433
DOI
|
75 |
Ambrosi P, Mouly-Bandini A, Attarian S and Habib G (2009) Heart transplantation in 7 patients form a single family with limb-girdle muscular dystrophy caused by lamin A/C mutation. Int J Cardiol 137, e75-76
DOI
|
76 |
Dyck JD, David TE, Burke B, Webb GD, Henderson MA and Fowler RS (1987) Management of coronary artery disease in Hutchinson-Gilford syndrome. J Pediatr 111, 407-410
DOI
|
77 |
Pendas AM, Zhou Z, Candinanos J et al (2002) Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 31, 94-99
DOI
|
78 |
Fong LG, Ng JK, Lammerding J et al (2006) Prelamin A and lamin A appear to be dispensable in the nuclear lamina. J Clin Invest 116, 743-752
DOI
|
79 |
Melcon G, Kozlov S, Cutler DA et al (2006) Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and Myo D pathways during muscle regeneration. Hum Mol Genet 15, 637-651
DOI
|
80 |
Ozawa R, Hayashi YK, Ogawa M et al (2006) Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles. Am J Pathol 168, 907-917
DOI
|